Breathe Well-being raises Rs 50 Cr in pre-series B funding

• ByStartupStory     |    January 19, 2023

50 crore rupees were raised for BREATHE WELL-BEING in a Pre-Series B deal that was jointly led by 3One4 Capital, Accel, and General Catalyst. Supermorpheus and FounderBank Capital also took part in the round. 

In order to improve the client experience, the business will use the cash to strengthen its coaching academy, grow its core workforce, and scale up its technological platform. 

The health tech start-up was founded by Rohan Verma, a former employee of McKinsey, and Aditya Kaicker, a former employee of Accenture, with the goal of providing easy-to-use alternatives to medications for the treatment of Type 2 Diabetes.

According to the company, the American Diabetes Association, the European Society of Endocrinology, and the American Association of Clinical Endocrinology have all published clinical evidence in their respective publications, making them the first digital health tech platform in Asia to do so.

Rohan Verma, co-founder and CEO of Breathe Well-being, said, “We are eying for a Diabetes Mukt Bharat (Diabetes Free India) with the aim to reverse diabetes for one Million Indians by 2025 and we are well on track to achieve that goal. The referral is our strongest growth lever, especially in non-metros and more than half our customers come through word of mouth.”

Dr. P K Goyal, MBBS, MD and DNB General Medicine, Fortis Hospital, New Delhi, said, “According to the latest guidelines by ADA, the first line of therapy for Type 2 Diabetes is diabetes education and lifestyle modifications. The biggest challenge any medical practitioner faces with diabetic patients is the time required for diabetes education and customizing lifestyle modifications to create behavioral change. This is exactly where Breathe Well-being has proven to be a big boon in my practice. Complimenting my medical practice with powerful lifestyle modifications powered by Breathe is helping my patients get outstanding results for their diabetes management and remission.”

Follow Startup Story